A

Abbott India Ltd

Pharmaceuticals

MIDCAP

Pharmaceuticals

Live Performance vs 

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 6 analysts offering recommendations for Abbott India Ltd

83%

Buy

0%

Hold

17%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio49.0450.94
PB Ratio15.936.51
Dividend Yield1.48%0.52%

Understand what these metrics mean. 

About the company

A

Abbott India Ltd

Abbott India is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions